1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

02 Dec 2022
Admin
News Article

Fujifilm Launches $60 Million Vc Fund For Early-Stage Biotech

Tokyo-Based Fujifilm Announced That It Has Launched A Strategic Life Sciences Investment Fund.Fujifilm Kicked Off The Fund With An Initial Investment Of 7 Billion Jpy (Approximately $60 Million). The Fund Will Be Used To Target Partnerships With Promising Early-Stage Biotechnology Companies To Enhance Fujifilm'S Life Sciences Portfolio. "Fujifilm Is Considering A Wide Range Of New And Innovative Business Constructs In Order To Cultivate And Foster Relationships With Emerging Biotechs To Create New, And Strengthen Existing, Businesses," The Company Said In A Press Release. The Fund Will Be Managed By The Life Sciences Corporate Venture Capital (Ls-Cvc), A New Group Established Within Fujifilm'S Life Sciences Strategy Headquarters In Tokyo. The Life Sciences Strategy Headquarters Was Launched In April 2021, Designed To Plan And Promote An Integrated Strategy To Accelerate Business Growth In Life Sciences. The Life Sciences Strategy Headquarters Is In Charge Of Managing And Spending The Fund'S Resources And Creating A Business Development Timeline With Biotech Startups. The Ls-Cvc'S Mission Is To Accelerate Business Growth Within The Life Sciences Industry, Specifically Through Contract Biopharmaceutical Development And Manufacturing, Drug Discovery Research Markets And Industrial Cell Culture Media. Starting With Fujifilm'S Life Science Strategic Business Offices In Dusseldorf, Germany And Cambridge, Massachusetts, The Company Will Reach Out To Early-Stage Biotechnology Companies To Offer Funding Deals And Partnerships. In Addition To Managing This New Fund, The Venture Capital Group Will Also Now Be Managing Fujifilm'S Entire Life Science Investment Portfolio. "In Many Cases, Early-Stage Companies Are The First To Develop Cutting-Edge Technologies And Innovative Business Models. I Believe Ls-Cvc Activities Will Enable Us To Speedily Develop New Partnerships With Such Promising Companies And To Deliver Value To Society Through Innovative Products," Said Takatoshi Ishikawa, General Manager Of Fujifilm'S Life Sciences Strategy Headquarters. For Many People Worldwide, Fujifilm'S Brand Is Associated With Their Photography Business That Started In 1934. However, In The 1980S, Fujifilm Started Using Their Digital Technologies For Medical Applications, Starting With Computed Radiography. The Company Is Now A Global Leader In Several Life Sciences Markets, Including Photoacoustic Imaging, Spina Bifida Therapies, Recombinant Cell Culture Supplements, Assisted Reproductive Technology And Synapse And Cardiology Imaging Solutions, The Latter Of Which Fujifilm Was Ranked "Best In Klas" For Its Three Synapse

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!